Target intelligence / Profile preview

Immunoglobulin heavy variable 1-68 (IGHV1-68)

Target
IGHV1-68
Molecular classification
Immunoglobulin variable region gene segment, Immunoglobulin superfamily, Other
01

Overview

Immunoglobulin heavy variable 1-68 (IGHV1-68) is a gene segment encoding the variable region of the heavy chain in human immunoglobulins (antibodies). This gene is part of the IGH locus on chromosome 14 (14q32.33) and contributes to the diversity of the immunoglobulin (antibody) repertoire through V(D)J recombination, enabling the immune system to recognize a broad range of antigens. The IGHV1-68 segment is classified as a variable (V) gene and encodes the first part of the antigen-binding domain of the heavy chain. It is not a functional antibody by itself, nor a therapeutic target, but rather one of many germline segments that are selected and rearranged during B-cell development. Some sources indicate that it may also be a pseudogene, meaning it is non-functional in certain references.\n\nIGHV1-68 should not be equated to a conventional drug target like a receptor, transporter, or enzyme; it is a genomic segment. Mutations, polymorphisms, or biased usage of similar immunoglobulin V-genes (such as IGHV1-69) can have immunological relevance, but IGHV1-68 itself is not a distinct target for drugs.\n\nIf you are interested in immunoglobulin heavy chain variable regions as disease biomarkers, predictors of response, or engineered targets (such as monoclonal antibody engineering), that typically involves entire variable regions in the context of antibody genes, not isolated IGHV gene segments.

Other names
1-68PIGHV168IGHV1-68
02

Mechanism of action

None (not a protein target for drug binding; is a genetic segment encoding part of antibody variable region)

03

Biological functions

Antigen recognition (contributes to specificity of antibodies through the variable region)Generation of antibody diversity via V(D)J recombinationAdaptive immune response
04

Disease associations

Other (Not directly implicated in disease as a target, but certain alleles or usage patterns of variable heavy genes can be associated with immune response profiles or susceptibilities)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 1-68 (IGHV1-68).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 1-68 (IGHV1-68).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call